Редактирование: Alex Zhavoronkov (раздел)

==Career==
He is the co-founder and CEO of Insilico Medicine, a [[deep learning]] company focused on drug discovery<ref>[http://www.pharmaceutical-journal.com/news-and-analysis/features/artificial-intelligence-will-it-change-the-way-drugs-are-discovered/20204085.article Artificial Intelligence: will it change the way drugs are discovered? Pharmaceutical Journal, The Journal of the Royal Pharmacological Society]</ref> and biomarker development for aging and aging-associated diseases located at the Emerging Technology Centers of the Johns Hopkins University.<ref>[https://www.genomeweb.com/informatics/silico-medicine-opens-us-office-prepares-launch-drug-discovery-software-aging-re GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014]</ref><ref>[http://www.baltimoresun.com/business/bs-bz-insilico-medicine-raise-20170223-story.html Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017]</ref>

Since 2011, Dr. Zhavoronkov authored and co-authored over 108 scientific articles published in refereed journals<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works&sortby=pubdate Google Scholar by Publication Date] Google Scholar by Publication Date</ref> with over 85 papers referenced in [[PubMed]].<ref name="Pubmed">[https://www.ncbi.nlm.nih.gov/pubmed/?term=zhavoronkov%2Ba PubMed Bibliography] Pubmed</ref> Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development, and aging research.<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works Google Scholar by Citation] Google Scholar by Citation</ref> 

In November 2017 together with the collaborators from the [https://www.BitFury.com BitFury Group] he proposed the application of the deep learning techniques and [[blockchain]] technology for managing human life data<ref>[https://sk.ru/news/b/news/archive/2017/11/21/skolkovo-scientist-says-ai-and-blockchain-could-accelerate-biomedical-research.aspx Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research]</ref>, <ref> [https://www.inverse.com/article/39129-bitcoin-tech-consumers-blockchain Bitcoin Tech Can Let You Decide Who Buys Your Data, Says Medical Startup]</ref>, <ref>[https://motherboard.vice.com/en_us/article/j5dq8b/insilico-blockchain-medical-data-cryptocurrency This Biotech Company Wants You to Give it Selfies and Blood Tests in Exchange for Cryptocurrency]</ref>,<ref> [] </ref> and presented the concept at the [[Singularity University]] Exponential Medicine conference in San Diego.<ref>[https://www.youtube.com/watch?v=NAAXot65-9g&feature=youtu.be&t=9h26m43s Alex Zhavoronkov presentation at the Exponential Medicine]</ref><ref>[https://singularityhub.com/2017/11/19/drug-discovery-ai-to-scour-a-universe-of-molecules-for-wonder-drugs/ Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs]</ref>

Dr. Zhavoronkov is the editor of ''Aging''<ref>[http://www.aging-us.com/editorial-board Aging Editorial Board]</ref> and associate editor of Frontiers in Genetics of Aging.<ref>[https://www.frontiersin.org/journals/genetics/sections/genetics-of-aging#editorial-board Frontiers in Genetics of Aging Editorial Board]</ref> He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors <ref>[https://www.newscientist.com/article/mg22429894-000-everyday-drugs-could-give-extra-years-of-life/ New Scientist report from the International Symposium on Geroprotectors in Basel]</ref> as part of the EMBO/Basel Life.<ref>[https://www.basellife.org/aging-and-drug-discovery 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland]</ref>